Avanos Medical Accounts Payable

Avanos Medical (AVNS) currently reports a accounts payable of $52M as of March 2026. That compares with $46M in the prior-year period — up 13.7% year over year. Use the charts on this page to explore Avanos Medical's accounts payable history and peer comparisons.

Avanos Medical's accounts payable increased from $46M to $52M — a 13.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avanos Medical reported $52M in accounts payable as of March 2026. That compares with $46M in the prior-year period — up 13.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $52M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avanos Medical, and consider following AVNS for alerts when major investors trade the stock.

Avanos Medical is classified in the Healthcare sector. On accounts payable, it currently shows $52M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVNS with unrelated industries.